간암 줄기세포의 기원

키워드

참고문헌 (51)

1. Lafaro KJ, "Epidemiology of hepatocellular carcinoma", Surg Oncol Clin N Am, 24, pp.1~17 (2015)
2. 윤승규, "The Biology of Cancer Stem Cells and Its Clinical Implication in Hepatocellular Carcinoma", Gut and Liver, 6(1), pp.29~40 (2012), 거트앤리버 발행위원회
3. Sasaki M, "Clinicopathological significance of ‘subtypes with stem-cell feature’ in combined hepatocellular-cholangiocarcinoma", Liver Int, 35, pp.1024~1035 (2015)
4. Bucher NLR, "Regeneration of liver and kidney" (1971), Little Brown
5. Duncan AW, "Stem cells and liver regeneration", Gastroenterology, 137, pp.466~481 (2009)
6. Zajicek G, "The streaming liver", Liver, 5, pp.293~300 (1985)
7. Fellous TG, "Locating the stem cell niche and tracing hepatocyte lineages in human liver", Hepatology, 49, pp.1655~1663 (2009)
8. Eckersley-Maslin MA, "Bone marrow stem cells and the liver: are they relevant?", J Gastroenterol Hepatol, 24, pp.1608~1616 (2009)
9. Almeida-Porada G, "Formation of human hepatocytes by human hematopoietic stem cells in sheep", Blood, 104, pp.2582~2590 (2004)
10. Shackel N, "In pursuit of the “Holy Grail”--stem cells, hepatic injury, fibrogenesis and repair", Hepatology, 41, pp.16~18 (2005)
11. Wang X, "Cell fusion is the principal source of bone-marrow-derived hepatocytes", Nature, 422(6934), pp.897~901 (2003)
12. Alison MR, "Hepatocytes from non-hepatic adult stem cells", Nature, 406(6793), pp.257~ (2000)
13. Theise ND, "Teperman L, et al. Liver from bone marrow in humans", Hepatology, 32, pp.11~16 (2000)
14. Ying QL, "Changing potency by spontaneous fusion", Nature, 416(6880), pp.545~548 (2002)
15. Lagasse E, "Purified hematopoietic stem cells can differentiate into hepatocytes in vivo", Nat Med, 6, pp.1229~1234 (2000)
16. Jang YY, "Hematopoietic stem cells convert into liver cells within days without fusion", Nat Cell Biol, 6, pp.532~539 (2004)
17. Harris RG, "Lack of a fusion requirement for development of bone marrow-derived epithelia", Science, 305(5680), pp.90~93 (2004)
18. Zeisberg M, "Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition", J Biol Chem, 282(32), pp.23337~23347 (2007)
19. Fausto N, "Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells", Hepatology, 39, pp.1477~1487 (2004)
20. Jirtle RL, "Modulation of insulin-like growth factor-II", mannose 6-phosphate receptors and transforming growth factor-beta 1 during liver regeneration, 1991, pp.266(33), 22444~22450
21. Marquardt JU, "Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications", J Hepatol, 53, pp.568~577 (2010)
22. Reya T, "Stem cells, cancer, and cancer stem cells", Nature, 414(6859), pp.105~111 (2001)
23. Sell S, "Liver cancer stem cells", J Clin Oncol, 26, pp.2800~2805 (2008)
24. Oishi N, "Novel therapeutic strategies for targeting liver cancer stem cells", Int J Biol Sci, 7, pp.517~535 (2011)
25. Coulouarn C, "Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties", Oncogene, 28, pp.3526~3536 (2009)
26. Pineau P, "miR-221 overexpression contributes to liver tumorigenesis", Proc Natl Acad Sci U S A, 107, pp.264~269 (2010)
27. Ma S, "miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1", Cell Stem Cell, 7, pp.694~707 (2010)
28. Wong QW, "MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1", Gastroenterology, 135, pp.257~269 (2008)
29. Wong QW, "MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling", Clin Cancer Res, 16, pp.867~875 (2010)
30. Ji J, "Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells", Hepatology, 50, pp.472~480 (2009)
31. Libbrecht L, "Hepatic progenitor cells in human liver diseases", Semin Cell Dev Biol, 13, pp.389~396 (2002)
32. Theise ND, "The canals of Hering and hepatic stem cells in humans", Hepatology, 30, pp.1425~1433 (1999)
33. Kordes C, "Hepatic stem cell niches", J Clin Invest, 123, pp.1874~1880 (2013)
34. Durnez A, "The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin", Histopathology, 49, pp.138~151 (2006)
35. Gerlach JC, "Perivascular mesenchymal progenitors in human fetal and adult liver", Stem Cells Dev, 21, pp.3258~3269 (2012)
36. Yin S, "CD133positive hepatocellular carcinoma cells possess high capacity for tumorigenicity", Int J Cancer, 120, pp.1444~1450 (2007)
37. Piao LS, "CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma", Cancer Lett, 315, pp.129~137 (2012)
38. Ma S, "Aldehyde dehydrogenase discriminates the CD133liver cancer stem cell populations", Mol Cancer Res, 6, pp.1146~1153 (2008)
39. Zhu Z, "Cancer stem", progenitor cells are highly enriched in CD133+CD44+population in hepatocellular carcinoma, 2010, pp.126, 2067~2078
40. Yang ZF, "Significance of CD90+ cancer stem cells in human liver cancer", Cancer Cell, 13, pp.153~166 (2008)
41. Yamashita T, "EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem", progenitor cell features, 2009, pp.136, 1012~1024
42. Park SC, "Identification of cancer stem cell subpopulations of CD34(+) PLC", PRF, Stem Cells Dev, pp.2015, 24[DOI]
43. Park SC, "Clonogenically culturing and expanding CD34+liver cancer stem cells in vitro", Stem Cells Dev (2015)
44. Holczbauer A, "Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types", Gastroenterology, 145, pp.221~231 (2013)
45. Bralet MP, "Demonstration of direct lineage between hepatocytes and hepatocellular carcinoma in diethylnitrosamine-treated rats", Hepatology, 36, pp.623~630 (2002)
46. Nagaki M, "Regulation of hepatic genes and liver transcription factors in rat hepatocytes by extracellular matrix", Biochem Biophys Res Commun, 210, pp.38~43 (1995)
47. Blaheta RA, "Dedifferentiation of human hepatocytes by extracellular matrix proteins in vitro: quantitative and qualitative investigation of cytokeratin 7, 8, 18, 19 and vimentin filaments", J Hepatol, 28, pp.677~690 (1998)
48. Xu J, "TGF-beta-induced epithelial to mesenchymal transition", Cell Res, 19, pp.156~172 (2009)
49. Dubois-Pot-Schneider H, "Inflammatory cytokines promote the retrodifferentiation of tumor-derived hepatocyte-like cells to progenitor cells", Hepatology, 60, pp.2077~2090 (2014)
50. Lowes KN, "Oval cell numbers in human chronic liver diseases are directly related to disease severity", Am J Pathol, 154, pp.537~541 (1999)
51. Eun JR, "Hepatoma SK Hep-1 cells exhibit characteristics of oncogenic mesenchymal stem cells with highly metastatic capacity", PLoS One, 9(10), pp.e110744~ (2014)

관련 논문AI추천